https://www.zonebourse.com/cours/action/PARATEK-PHARMACEUTICALS-I-18426416/actualite/Paratek-Pharmaceuticals-accuse-reception-de-la-lettre-de-NexPoint-Advisors-44215682/?utm_source=telegram&utm_medium=social&utm_campaign=share